Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury.
Joel CosteAlexandre KarrasAnnie RudnichiRosemary Dray-SpiraJacques PouchotPhilippe GiralMahmoud ZureikPublished in: Pharmacoepidemiology and drug safety (2019)
Although the overall risk of AKI appears moderately increased, more attention should be paid to renal function in subjects taking statins for primary prevention both in clinical practice and from a research viewpoint.